Brown: Risk Weighti...
Health Care: Drugs
Zogenix Inc. (ZGNX: NASDAQ)
$1.60 0.00 | 0.00%
05/17/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 72.41M | 47.11M | 50.32M | 48.78M | 52.99M | 77.22M | 76.62M |
| Shares Bought | 29.80M | 6.39M | 6.81M | 4.88M | 31.46M | 39.09M | 39.09M |
| Shares Sold | 8.70M | 8.62M | 8.40M | 8.49M | 1.08M | 1.13M | 1.10M |
Portfolios with ZGNX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserMy stocks
- UserJaheer
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
Latest ZGNX Headlines from TheStreet
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin 05.10.13 | 07:05 am
- Zogenix Reports First Quarter 2013 Financial Results 05.09.13 | 04:05 pm
- Zogenix Announces Conference Call And Webcast To Present First Quarter 2013 Financial Results 05.03.13 | 07:05 am
- Zogenix Reports Positive Top-Line Results From Extended Relday(TM) Phase 1 Clinical Trial 05.02.13 | 07:05 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Zogenix And Battelle Extend DosePro Co-Marketing Partnership 03.27.13 | 08:03 am
- Zogenix Reports Fourth Quarter And Full Year 2012 Financial Results 03.15.13 | 07:03 am
- Zogenix Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2012 Financial Results 03.07.13 | 07:03 am
- Zogenix Provides Update On Zohydro(TM) ER Regulatory Review 02.26.13 | 08:02 pm
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
Press Releases for ZGNX
- DURECT Announces Positive Results From Reldayâ¿¢ Phase 1 Clinical Trial - PR Newswire 01.03.13 | 07:01 am
- Fast-Acting Migraine Treatment Highlighted During National Migraine Awareness Month - PR Newswire 06.06.11 | 08:06 am
Partner Headlines for ZGNX
- Zogenix Says FDA Panel Will Review Zohydro on Dec. 7th - Benzinga 11.08.12 | 09:11 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- Healthcare Business Review: Sarepta Shoots Into Outer SPACE, Roche Gets GOOD News - Wall St. Cheat Sheet 07.25.12 | 08:07 am
- Earnings Preview: Covidien - Analyst Blog - Zacks 07.23.12 | 10:07 am
- Healthcare Biz Review: Vivus' Second TRY, Intuitive Surgical's PROSPECTS - Wall St. Cheat Sheet 07.16.12 | 12:07 pm
- Benzinga's Microcap Movers for Friday July 13, 2012 - Benzinga 07.14.12 | 04:07 pm
- Company News for March 12, 2012 - Corporate Summary - Zacks 03.12.12 | 10:03 am
- Zogenix: Smart Biotech Buy Before Earnings - Seeking Alpha 03.05.12 | 07:03 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- Biotech Catalysts for Third Quarter - Seeking Alpha 06.24.11 | 06:06 pm
